Interstitial lung changes and persistent <scp>COVID</scp>‐19 in a patient with follicular lymphoma: A case report-Reference-Cited by-同舟云学术

Interstitial lung changes and persistent COVID‐19 in a patient with follicular lymphoma: A case report

Published:2024-02 Issue:2 Volume:12 Page:
ISSN:2051-3380
Container-title:Respirology Case Reports
language:en
Short-container-title:Respirology Case Reports

Author:

Yomota Makiko¹^ORCID,Tanaka Masaru²,Kobayashi Takayuki¹,Kitano Masatake¹,Ikeda Saori¹,Kanemasa Yusuke³,Yanagawa Noriyo⁴,Hosomi Yukio¹

Affiliation:

1. Department of Respiratory Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan

2. Department of Infectious Diseases Tokyo Metropolitan Komagome Hospital Tokyo Japan

3. Department of Oncology Tokyo Metropolitan Komagome Hospital Tokyo Japan

4. Department of Radiology Tokyo Metropolitan Komagome Hospital Tokyo Japan

Abstract

AbstractWe herein report a case of interstitial lung changes in a patient with prolonged coronavirus disease 2019 (COVID‐19) with follicular lymphoma receiving rituximab and bendamustine who recovered after treatment with a combination therapy consisting of corticosteroids and immunosuppressive agents. There is currently no treatment strategy for prolonged pneumonitis following COVID‐19, which can be life‐threatening for immunocompromised patients. Thus, further investigation is warranted.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rcr2.1298

Reference15 articles.

1. Immunocompromised Patients with Protracted COVID-19: a Review of “Long Persisters”

2. Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies

3. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient

4. Management of Persistent SARS-CoV-2 Infection in Patients with Follicular Lymphoma

5. Does COVID-19 pneumonia signify secondary organizing pneumonia?: A narrative review comparing the similarities between these two distinct entities